Company news: IMS Health, Havas Drive, Healthline Networks

Share this article:
IMS Health launched the IMS Institite for Healthcare Informatics, a bigthink initiative focusing on the use of medical information globally, the future global role of biopharmas, the role of innovation in health system products, processes and delivery systems, and advancement of healthcare agendas in developing nations.

Family practitioners are consistently the physicians most targeted by industry emails, but specialty physicians are more likely to open and click, a survey by Cegedim's SK&A unit found. In 2010, around 17% of all emails targeted family practitioners, but the highest open rates were for trauma surgeons (13.4%), hepatologists (13.2%) and dermatopathologists (11.1%).

Healthline Networks added several publishing partners to its media network, including Ask.com, DoctorOz.com, DailyStrength, DailyRx, Inspire and the Forward Health group, (Women's Health Base, Men's Health Base, All-Allergines.com and Good Cholesterol Count.com). The San Francisco-based firm claims a potential reach of 43 million unique visitors each month.

Havas Drive launched a unit offering “patient-centric services geared toward persons with disabilities and those undergoing rehabilitative therapies.” The new unit will offer strategic and technological products – including tablets, gaming consoles, haptic interfaces, virtual prosthetics, adaptive therapies, text-to-speech functionality and Second Life – serving populations with low vision, blindness, autism, degermative illnesses, behavioral disorders, cognitive difficulty and the hearing impaired.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.